ClinicalTrials.Veeva

Menu
C

CT Clinical Research | Cromwell, CT

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

JZP150
BI 1569912
Cariprazine
Dasotraline
Pimavanserin
Zavegepant
BHV-3500
Quetiapine
Simufilam
BI 1358894

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 17 total trials

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the treatme...

Enrolling
Acute Migraine
Drug: Placebo
Drug: Elismetrep (K-304) Dose level 3

This study is open to people aged 18 years or older with schizophrenia. People can join the study if they are willing to use a smartphone app called...

Enrolling
Schizophrenia
Device: Digital therapeutic (CT-155)

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18...

Enrolling
Acute Treatment of Migraine
Drug: Rimegepant (PF-07899801)
Locations recently updated

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in chil...

Enrolling
Pediatric Migraine
Drug: Rimegepant/BHV3000
Drug: Matching placebo

Trial sponsors

Pfizer logo
AbbVie logo
Boehringer Ingelheim logo
Acadia Pharmaceuticals logo
C
Jazz Pharmaceuticals logo
K
Purdue Pharma logo
Sumitomo Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems